Agree that 1801 has huge potential. However, I'd be surprised if we see it fully developed as a BOT product. Once SB gets FDA approval and we have a growing revenue stream, BOT will finally be materially derisked to a certain extent. Vinnie and his crew are masters of getting a deal done with big pharma. Matt has never made a secret that a buyout by BP is the likely end goal. Further trials and research takes heaps of time and money and has inherent risk. If they can negotiate a deal that they feel fairly values the huge potential of 1801, and other products, whilst acknowledging the development costs and risks, they'll definitely get the deal done. Will be extremely interesting to see how it all unfolds. In Vinnie we trust
- Forums
- ASX - By Stock
- Botanix Antimicrobial Pipeline Remains Key
Agree that 1801 has huge potential. However, I'd be surprised if...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
33.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $527.6M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32083 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 50000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32083 | 0.480 |
2 | 44404 | 0.470 |
1 | 2000 | 0.460 |
8 | 38807 | 0.450 |
1 | 20000 | 0.430 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 20000 | 2 |
0.330 | 50000 | 1 |
0.335 | 10019 | 2 |
0.345 | 2874 | 1 |
0.350 | 635431 | 12 |
Last trade - 16.16pm 20/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online